Physician’s Briefing Weekly Coronavirus Roundup
CDC: Life Expectancy for U.S. Population Increased in 2019
And age-adjusted rate of drug overdose deaths increased from 20.7 to 21.6 per 100,000 from 2018 to 2019
Dietary Advanced Glycation End-Product Intake, Wheezing Linked
Higher AGE intake associated with wheeze-disrupted sleep and exercise, wheezing requiring prescription meds in children
Care Rationing Being Considered by California Hospitals
California has more than twice as many hospitalized COVID-19 patients as it did at its previous peak in July
Tagrisso Approved as Adjuvant Therapy for NSCLC With EGFR Mutations
Current approval of the once-daily tablet indicated for patients who have undergone complete tumor removal
Risk for Death, Complications Higher With COVID-19 Versus Flu
Risk for mechanical ventilation use, admission to intensive care, longer length of stay increased for COVID-19 versus flu
Low U.S. Flu Rates Seen as Pandemic Rages
Many more people are getting flu shots to avoid the risk for getting both the flu and COVID-19
Cadmium Burden Linked to Mortality From Flu, Pneumonia
Risk for related mortality increased with urinary cadmium in the 80th versus the 20th percentile in whole population, never smokers in NHANES-III
Immune Checkpoint Inhibitor Therapy Tied to Cardiac Event Risk
Increased risks persist beyond six months for patients with lung cancer receiving PD1i and with malignant melanoma receiving CTLA-4i
Tocilizumab Cuts Progression to Ventilation or Death in COVID-19
But death from any cause by day 28 in those hospitalized with COVID-19 pneumonia did not differ for tocilizumab versus placebo
